The Impact of New Weight Loss Drugs on Dietetics By Carrie Dennett, MPH, RDN Today’s Dietitian Vol. 26 No. 9 P. 14 What’s changed for weight-inclusive and weight management dietitians?
Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...
Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...
“I’m playing doctor,” Bookless said, describing her foray into the world of do-it-yourself GLP-1 medication, injections ...
A doctor friend said Mounjaro was perfect for people in my situation, but a dodgy prescription left me sick and nauseous ...
Viking Therapeutics (VKTX) released new ... new weight-loss drug alternatives to current market leaders like Wegovy, Zepbound ...
Weight loss injections can significantly ease arthritis symptoms in people struggling with obesity, a new study has shown.
Novo's development chief, Martin Holst Lange, has shown optimism about the drug's promise, though he refrained from making ...
An injection pen of Zepbound, Eli Lilly’s weight-loss drug, is displayed in New York City, December 11 ... Novo and Lilly ...
Holidays for me are always destinations with a foodie theme. Indeed, I fell in love with my husband Pascal while on holiday ...
Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...
The updated AAP clinical guidelines on obesity treatment recommend offering the full spectrum of care upon initial obesity ...